• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马体内普罗帕酮的动力学。房室模型与非房室模型的比较分析。

Propafenone kinetics in the horse. Comparative analysis of compartmental and noncompartmental models.

作者信息

Puigdemont A, Riu J L, Guitart R, Arboix M

机构信息

Departament de Farmacologia, Facultat de Veterinària, Universitat Autònoma de Barcelona, Bellaterra, Spain.

出版信息

J Pharmacol Methods. 1990 Apr;23(2):79-85. doi: 10.1016/0160-5402(90)90035-j.

DOI:10.1016/0160-5402(90)90035-j
PMID:2332982
Abstract

The propafenone kinetics after intravenous (i.v.) administration have been studied in the horse by a comparative analysis of compartmental and noncompartmental models. The pharmacokinetic parameters showed a large distribution (Vdss = 1021 +/- 211 L) and a high clearance (CI = 7019 +/- 1746 mL/min) of the drug. The plasma concentrations were very low, under 1 microgram/mL, in most cases; after 30 min these concentrations can be considered as nonefficient for the treatment of arrhythmia. There were no significant differences between pharmacokinetic parameters found with the use of compartmental and noncompartmental models.

摘要

通过房室模型和非房室模型的比较分析,对马静脉注射普罗帕酮后的动力学进行了研究。药代动力学参数显示该药物具有较大的分布容积(稳态分布容积Vdss = 1021±211 L)和较高的清除率(CI = 7019±1746 mL/分钟)。在大多数情况下,血浆浓度非常低,低于1微克/毫升;30分钟后,这些浓度可被认为对心律失常治疗无效。使用房室模型和非房室模型所发现的药代动力学参数之间没有显著差异。

相似文献

1
Propafenone kinetics in the horse. Comparative analysis of compartmental and noncompartmental models.马体内普罗帕酮的动力学。房室模型与非房室模型的比较分析。
J Pharmacol Methods. 1990 Apr;23(2):79-85. doi: 10.1016/0160-5402(90)90035-j.
2
Tissue distribution of propafenone in the rat after intravenous administration.静脉注射后普罗帕酮在大鼠体内的组织分布。
Eur J Drug Metab Pharmacokinet. 1991 Jan-Mar;16(1):23-7. doi: 10.1007/BF03189870.
3
Use of propafenone for conversion of chronic atrial fibrillation in horses.普罗帕酮用于马慢性心房颤动转复的研究。
Am J Vet Res. 2009 Feb;70(2):223-7. doi: 10.2460/ajvr.70.2.223.
4
Bioavailability of an extemporaneous suspension of propafenone made from tablets.由片剂制成的普罗帕酮临时混悬液的生物利用度。
Biopharm Drug Dispos. 2006 Jul;27(5):241-5. doi: 10.1002/bdd.505.
5
Intravenous and oral propafenone for treatment of tachycardia in infants and children: pharmacokinetics and clinical response.静脉注射和口服普罗帕酮治疗婴幼儿心动过速:药代动力学与临床反应
J Clin Pharmacol. 1998 Jun;38(6):496-501. doi: 10.1002/j.1552-4604.1998.tb05786.x.
6
Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings.美西律与普罗帕酮在人体内的药代动力学和药效学相互作用。
Clin Pharmacol Ther. 2000 Jul;68(1):44-57. doi: 10.1067/mcp.2000.108023.
7
Hemodialysis removal of propafenone.血液透析清除普罗帕酮。
Pharmacotherapy. 1989;9(5):331-3. doi: 10.1002/j.1875-9114.1989.tb04145.x.
8
Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers.在人类志愿者中比较克拉霉素、舒马曲坦、普罗帕酮、对乙酰氨基酚(扑热息痛)和苯巴比妥的微剂量与治疗剂量的药代动力学。
Eur J Pharm Sci. 2011 Jun 14;43(3):141-50. doi: 10.1016/j.ejps.2011.04.009. Epub 2011 Apr 20.
9
Influence of hepatic dysfunction on the pharmacokinetics of propafenone.肝功能不全对普罗帕酮药代动力学的影响。
J Clin Pharmacol. 1987 May-Jun;27(5):384-9. doi: 10.1002/j.1552-4604.1987.tb03035.x.
10
Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group.
Clin Pharmacol Ther. 1989 May;45(5):535-41. doi: 10.1038/clpt.1989.69.

引用本文的文献

1
Tissue distribution of propafenone in the rat after intravenous administration.静脉注射后普罗帕酮在大鼠体内的组织分布。
Eur J Drug Metab Pharmacokinet. 1991 Jan-Mar;16(1):23-7. doi: 10.1007/BF03189870.